Alterity Therapeutics (ATHE) Times Interest Earned (2019)
Alterity Therapeutics' (ATHE) quarterly Times Interest Earned came in at $2280.8 in Q4 2019.
Alterity Therapeutics (ATHE) Times Interest Earned (2019) Analysis & Trends
Alterity Therapeutics' Times Interest Earned history runs 1 years deep, the most recent figure standing at $2280.8 for Q4 2019.
- On a quarterly basis, Times Interest Earned changed N/A year-over-year to $2280.8 in Q4 2019; TTM through Dec 2019 was $13541.9, a N/A change from a year earlier, with the FY2025 full-year figure at -$1962.1, up 26.81% from the prior year.
- Times Interest Earned was little changed at $2280.8 in Q4 2019 per ATHE's latest filing.
- Across five years, Times Interest Earned topped out at $2280.8 in Q4 2019 and bottomed at $2280.8 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Alterity Therapeutics | 29.68 Bn | 29.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 2,280.81 |